INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

UTHRUNITED THERAPEUTICS Corp

CIK 0001082554

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 50
Max Insider Score34
Connections8with evidence

UTHR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M—
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Holdsevidence
    RENAISSANCE TECHNOLOGIES LLC1.3% of reported portfolio · Aug 13, 2026
  • ← Insider ofevidence
    Edgemond JamesCFO AND TREASURER · Apr 10, 2026
5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M
$14K
130 sh
Sep 14, 2026
Sep 15, 2026
traded Sep 14, 2026
+1d
SEC FORM 4

Evidence

20
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale
SELL$66K
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC FORM 4

Evidence

17
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale
SELL$50K
98 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC FORM 4

Evidence

13
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.35M
10.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$504K
880 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$885K
1,543 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$254K
442 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$581K
1,010 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$397K
687 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$289K
500 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$197K
340 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$284K
488 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$573K
983 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$282K
482 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$589K
1,009 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$139K
238 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

0
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$806K
1,398 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC FORM 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$232K
400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

0
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$23K
40 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.07M
1,860 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$347K
601 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$693K
1,210 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$660K
1,154 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

13
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.35M
10.0K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$160K
281 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$838K
1,457 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$780K
1,354 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

0
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$23K
40 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

0
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$925K
1,603 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

3
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
1,956 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$322K
560 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

20
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.35M
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$94K
162 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.02M
1,756 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$710K
1,224 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$659K
1,139 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$934K
1,617 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$915K
1,586 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

6
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
45 sh
Mar 17, 2026Mar 17, 2026
traded Mar 17, 2026
+0dSEC FORM 4

Evidence

5
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 17, 2026Feb 17, 2026
traded Feb 17, 2026
+0dSEC FORM 4

Evidence

10
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC FORM 4

Evidence

13
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

14
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.15M
7,875 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

16
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$29K
63 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$170K
372 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

23
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$173K
377 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$123K
268 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$125K
271 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

30
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$612K
1,322 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

30
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$568K
1,225 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

30
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$449K
966 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

26
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$265K
568 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

23
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$150K
321 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

34
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$736K
1,573 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

31
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$212K
451 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

28
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$40K
84 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Tracey KevinDirector · Jan 23, 2026
  • ← Insider ofevidence
    Benkowitz MichaelPRESIDENT AND COO · Dec 30, 2025
  • ← Insider ofevidence
    Malcolm JanDirector · Dec 12, 2025
  • ← Insider ofevidence
    Mesa NildaDirector · Dec 10, 2025

    • Lobbying

    $160K reported · de-duplicated
    2026 Q2 $80K via firms2026 Q1 $80K via firms
    • TIBER CREEK GROUP$80K2026 Q1 · posted Aug 26, 2026 · Health issues
    • TIBER CREEK GROUP$80K2026 Q2 · posted Aug 26, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.